Drug · DIN 02425637
ELELYSO
SINGLE-USE VIAL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 5, 2025; first marketed September 8, 2014.
- Drug Identification Number (DIN)
- 02425637
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Taliglucerase alfa A16AB11
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TALIGLUCERASE ALFA | 200 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 29, 2014: NOC 15648New Drug Submission (NDS)